✦ LIBER ✦
Cross-validation study of class III beta-tubulin as a predictive marker for benefit from adjuvant chemotherapy in resected non-small-cell lung cancer: analysis of four randomized trials
✍ Scribed by Reiman, T.; Lai, R.; Veillard, A. S.; Paris, E.; Soria, J. C.; Rosell, R.; Taron, M.; Graziano, S.; Kratzke, R.; Seymour, L.; Shepherd, F. A.; Pignon, J. P.; Seve, P.
- Book ID
- 119954044
- Publisher
- Oxford University Press
- Year
- 2012
- Tongue
- English
- Weight
- 191 KB
- Volume
- 23
- Category
- Article
- ISSN
- 0923-7534
No coin nor oath required. For personal study only.